
英文名称:ACVR2A (C-6His), Human, Recombinant
货号:GPCK106
价格: ¥11880.00 ¥1680.00 ¥580.00 ¥17280.00
规格:
500μg
50μg
10μg
1mg
产品详情
产品信息
产品形态 | 液体 |
产品规格 | 500μg / 50μg / 10μg / 1mg |
表达宿主 | Human Cells |
序列信息 | Ala20-Pro134 |
检索号 | P27037 |
分子量 | 14.35 kDa |
表观分子量 | 28-38 kDa |
纯度 | > 95% as determined by reducing SDS-PAGE. |
内毒素 | < 0.1 EU/μg |
制剂 | Supplied as a 0.2 μm filtered solution of 20 mM PB, 300 mM NaCl, 10% Glycerol, 5% Trealose, pH 7.4. |
储存条件 | Store at ≤-70℃, stable for 6 months after receipt. Store at ≤-70℃, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. |
运输条件 | The product is shipped on dry ice/polar packs. Upon receipt, store it immediately at the temperature listed below. |
有效期 | 6个月 |
背景介绍 | Activin Receptor Type-2A is a Protein that in humans is encoded by the ACVR2A gene. ACVR2A is an activintype 2 Receptor. This gene encodes activin A type II Receptor. Activins are dimeric growth anddifferentiation factors which belong to the transforming Growth Factor-beta (TGF-beta) superfamily ofstructurally related signaling Proteins. Activins signal through a heteromeric complex of Receptor serinekinases which include at least two type I (I and IB) and two type II (II and IIB) Receptors. These Receptors areall transmembrane Proteins, composed of a Ligand-binding extracellular domain with cysteine-rich region, atransmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type IReceptors are essential for signaling; and type II Receptors are required for binding Ligands and forexpression of type I Receptors. Type I and II Receptors form a stable complex after Ligand binding, resultingin phosphorylation of type I Receptors by type II Receptors. Type II Receptors are considered to beconstitutively active kinases. |
产品推荐
相关推荐
• IL-1R-2/CD121b (C-6His), Mouse, Recombinant
• IL-22, Mouse, Recombinant
• IL-33/IL-1 F11/NF-HEV, Mouse, Recombinant
• IL-36γ/IL-1F9, Human, Recombinant
• RANKL/TNFSF11/TRANCE/CD254, Mouse, Recombinant
• Galectin-8/LGALS8/PCTA-1/Po66-CBP, Human, Recombinant
• β-NGF/NGF/NGFB (Glu19-Ala241), Human, Recombinant
• CXCL10/IP-10/Crg-2, Human, Recombinant
• CXCL5/ENA-78, Human, Recombinant
• LIF, Human, Recombinant
×